UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years Richard Peto, Jillian Boreham, Mike Clarke, Christina Davies, Valerie Beral

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Venezuela: violence, human rights, and health-care realities

Volume 83, Issue 1, Pages (July 2014)

How successful was the English teenage pregnancy strategy?

Volume 16, Issue 9, Pages (September 2015)

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

The benefits and harms of breast cancer screening

سرطان الثدي Breast Cancer

Rapid response to HPV vaccination crisis in Ireland

Living with HIV/AIDS The Lancet Volume 369, Issue 9566, (March 2007)

At high risk: becoming a mother in the Peruvian Andes

A visual insight The Lancet Volume 367, Issue 9519, (April 2006)

Intraoperative radiotherapy for early breast cancer

Volume 9, Issue 5, Pages (May 2008)

Long-term effects of hormone replacement therapy

New global estimates of malaria deaths

Aspirin in the prevention of cancer – Author's reply

Volume 375, Issue 9732, Pages (June 2010)

Volume 376, Issue 9754, (November 2010)

Cancer survivorship: a local and global issue

Expanding perception through the disordered brain

Ageing in the 21st century

Age-specific relevance of usual blood pressure to vascular mortality

Something for every body

Increase in US medication-error deaths

Adjuvant chemotherapy for rectal cancer – Authors' reply

Volume 382, Issue 9906, Pages (November 2013)

Disease and stigma The Lancet Volume 354, (December 1999)

Denny Vågerö, Robert Erikson

Allergen exposure and asthma

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study Nabihah Sachedina, MBBS, Prof.

Pharmacogenetic testing in the UK clinical setting

Body-mass index and mortality – Authors' reply

Michael J Goldacre, Jenny J Maisonneuve The Lancet

Psychological response and survival in breast cancer

GISSI-Prevenzione trial

Cold water immersion: sudden death and prolonged survival

Drama therapy The Lancet Volume 383, Issue 9933, (June 2014)

Barks and quacks: London's alcoholic remedies

Confessions of a journal junkie

Here's Johnny The Lancet Neurology Volume 7, Issue 5, (May 2008)

Waiting for change The Lancet Volume 369, Issue 9577, (June 2007)

The wonders of the recurated Wellcome Collection

Telling it like it isn't: truth and lies in a post-9/11 world

Volume 377, Issue 9760, Pages (January 2011)

Erratum The Lancet Neurology Volume 6, Issue 6, (June 2007)

Hidden from history? A brief modern history of the psychiatric “treatment” of lesbian and bisexual women in England Sarah Carr, Helen Spandler The Lancet.

Thank God for Richard Dawkins?

Low-technology approaches

Tristan's story The Lancet Volume 379, Issue 9827, (May 2012)

Fin-de-siècle Vienna: mental illness and modernism

UK classification of cannabis: is a change needed and why?

Hospital mortality and staff workload

Prescription for change

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Steven A Narod The Lancet Volume 349, Issue 9068, (June 1997)

GBD 2016 estimates problematic for South Africa

A remarkable report card on progress in COPD

CUP Incidence UK, 2012 (C77-80) CUP has the 10th highest number of new cancer cases each year in the UK England Wales Scotland N Ireland UK Male 3,730.

Erratum The Lancet Oncology Volume 3, Issue 8, (August 2002)

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Richard Dadd—painting from his mind's eye

Living in colour—American children, race, and wellbeing

Volume 349, Issue 9062, Pages (May 1997)

Lost childhoods The Lancet Volume 377, Issue 9771, (March 2011)

Menopausal hormone therapy and 20-year breast cancer mortality

Volume 375, Issue 9713, (February 2010)

Autism, maths, and sex: the special triangle

Volume 374, Issue 9694, Pages (September 2009)

Presentation transcript:

UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years Richard Peto, Jillian Boreham, Mike Clarke, Christina Davies, Valerie Beral The Lancet Volume 355, Issue 9217, (May 2000) DOI: 10.1016/S0140-6736(00)02277-7 Copyright © 2000 Elsevier Ltd Terms and Conditions

Recent decrease in UK and USA breast cancer mortality at ages 50–69 years Mean of rates at ages 50–54 years, 55–59 years, 60–64 years, 65–69 years. 1998 and provisional 1999 rates of 76–6 and 73–2 are for England and Wales only, where the 1997 rate was 79–2. The Lancet 2000 355, DOI: (10.1016/S0140-6736(00)02277-7) Copyright © 2000 Elsevier Ltd Terms and Conditions